Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VIVO Cannabis Inc. VVCIF

Healthcare Drug Manufacturers - Specialty & Generic
VIVO Cannabis Inc is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company's operating segment includes Cannabis, Patient Clinics, and Corporate. It generates maximum revenue from the Cannabis segment. The company has a presence across three geographical locations - Canada, Germany, and Australia.


OTCQB:VVCIF - Post by User

VIVO Cannabis Inc.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(850)
•••
Post by 1hot-techwomanon Mar 15, 2022 5:43pm
232 Views
Post# 34516664

Could Q4 bring profitability? As per Q3 comments !!!

Could Q4 bring profitability? As per Q3 comments !!!

Business Overview

In Q3 2021, VIVO began to focus on leveraging its assets to create value in the medical cannabis segment in Canada, Australia and Germany. VIVO believes that leveraging these assets will generate long-term shareholder value and accelerate its path to profitability.

Bring on Q4 :)

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities